Amyotrophic Lateral Sclerosis (ALS) is a progressive, severe, multisystem neurodegenerative disease that affects motor neurons and has a profound impact on patients’ lives. Explore Ferrer’s medical education resources, including accredited eLearnings, publications and other scientific content related to ALS.
neuroscience hub
At Ferrer, we work to advance scientific understanding and develop innovative therapies for people living with rare neurological diseases.
Our scientific focus is an expression of our purpose. We choose to focus on rare diseases and areas of high unmet need because we believe no one should be left behind simply because their condition is rare, complex or difficult to treat.
Through research, collaboration and engagement with patients, this hub brings together medical education resources on ALS and PSP, including congress content, clinical trial insights, publications and other scientific materials in one place.
ALS
PSP
Progressive Supranuclear Palsy (PSP) is a rare neurodegenerative disease characterised by progressive impairment of vision, movement, balance and cognition. Explore Ferrerʼs scientific and medical education content on PSP, including disease insights, our development programme and the mechanism of action underpinning our research.
STAY UPDATE
Receive curated updates on clinical research, medical education, key publications and Ferrer initiatives in rare neurological diseases. You can unsubscribe at any time.
